Category: Approval/Launch Region: North America · United States Company: Fresenius Kabi Usa Llc

Fresenius Kabi Targets Treatment Of Certain Seizures With Launch Of Generic Lacosamide Injection

Fresenius Kabi Targets Treatment Of Certain Seizures With Launch Of Generic Lacosamide Injection
Fresenius Kabi Announced Today The Immediate Availability In The U.S. Of Lacosamide Injection, Usp, A Generic Equivalent To Vimpat

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!